NIAID


Also found in: Acronyms.

National Institute of Allergy and Infectious Diseases

 (NIAID)
an institute of the national institutes of health; its research strives to understand, treat, and ultimately prevent infectious, immunologic, and allergic disorders affecting human beings.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

NIAID

National Institute of Allergy and Infectious Diseases.
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
To further enhance the clinical response in this patient group, SIRION licensed its LentiBOOST technology to NIAID. The NIAID will be entitled to apply this technology for early clinical development of its SCID-X1 trial as well as for its complete gene therapy portfolio including multiple stem-cell and T-cell programmes.
For year one of the study, NIAID has committed $720,000 on top of the Foundation's previously announced $3.8 million over the five years.
The HVTN 702 study begins just months after interim results were reported for HVTN 100, a predecessor clinical trial that found that the new vaccine regimen was safe for the 252 study participants and induced comparable immune responses to those reported in RV144, according to NIAID.
The test vaccine contains no thimerosal or adjuvant, according to NIAID. The institute plans to conduct additional trials in pregnant women of potential HlNl vaccines under development by other manufacturers.
NIAID supports a number of international research programs on infectious diseases, including HIV/AIDS.
As part of this support, NIAID will also act as sponsor of an additional investigationa l new drug (IND) application for VivaGel(TM) for prevention of genital herpes with the US Food and Drug Administration (FDA).
Greenberg of NIAID and his colleagues put the microbe into lab mice.
"Finding thousands of HSV-negative women for the new trial will be a significant challenge," said Pamela Mclnnes, D.D.S., deputy director of NIAID's Division of Microbiology and Infectious Diseases.
"Finding thousands of HSV-negative women for the new trial will be a significant challenge," said Pamela McInnes, D.D.S., who is deputy director of NIAID's Division of Microbiology and Infectious Diseases.
protests the denial by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health & Human Services (HHS), of its claim for the costs of filing and pursuing its protest, under request for proposals (RFP) No.
(13.) "NIAID Topical Microbicide Research Developing New Tools to Protect Women from HIV/AIDS and other STDs." Fact sheet.
The research programs at the National Institute of Allergy and Infectious Diseases (NIAID) are designed to take advantage of the recent outpouring of ideas from concerned academic and industrial scientists on ways to understand and combat potential agents of bioterrorism.